The anesthetic implications of opioid addiction

Perioperative Addiction: Clinical Management of the Addicted Patient

Volumn , Issue , 2012, Pages 73-93

  Lewis, Michael ^a   Souki, Fouad ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956470471     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-0170-4_4     Document Type: Chapter

References (88)

1. Substance Abuse and Mental Health Services Administration. Results from the 2008 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Rockville, MD; 2009.http://www.oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.pdf. Accessed 30 Sep 2010.
2. Manchikanti L, Singh A. Therapeutic opioids. A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(2 Suppl):S63-88.
3. Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94(1-3):38-47.
4. Kuczkowski K. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:357-8.
5. Birnbach DJ, Browne IM, Kim A, Stein DJ, Thys DM. Identification of polysubstance abuse in the parturient. Br J Anaesth. 2001;87:488-90.
6. Stoelting RK, Dierdorf SF. Psychiatric illness and substance abuse. In: Stoelting RK, Dierdorf SF, editors. Anesthesia and co-existing disease. 4th ed. New York: Churchill Livingstone; 2002. p. 629-54.
7. Gutstein Howard B, Akil Huda. “Chapter 21. Opioid Analgesics”. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11e: http://www.accessmedicine.com/content.aspx?aID=940653. Accessed 30 Sep 2010.
8. A narcotic painkiller tops Forbes’ list of the most prescribed medicines. http://www.forbes. com/2010/05/11/narcotic-painkiller-vicodin-business-healthcare-popular-drugs.html. Accessed 30 Sep 2010.
9. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the future national results on adolescent drug use: overview of key findings (NIH Publication No. 10-7583). Bethesda, MD: National Institute on Drug Abuse; 2009.
10. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000. Text revision: DSM-IV-TR.
11. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Drug Abuse Warning Network, 2007. National Estimates of Drug-Related Emergency Department Visits. Rockville, MD; 2010.
12. Cami J, Farré M. Drug addiction. N Engl J Med. 2003;349:975-86.
13. Savage S, Covington EC, Heit HA, Hunt J, Joranson D, Schnoll SH. American Academy of Pain Medicine, American Pain Society and American Society of Addiction Medicine. Definitions Related to the Use of Opioids for the Treatment of Pain:Consensus document; 2001.http://www.painmed.org/Workarea/DownloadAsset.aspx?id=3204. Accessed 30 Sep 2010.
14. Becerra L, Harter K, Gonzalez RG, Borsook D. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg. 2006;103:208-16.
15. Fukuda K. Intravenous opioid anesthetics. In: Miller RD, editor. Miller’s anesthesia. 6th ed. Philadelphia, PA: Elsevier; 2005.
16. Stoelting RK. Opioids agonists and antagonists. In: Stoelting RK, Hillier S, editors. Pharmacology & physiology in anesthetic practice. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2006. p. 87-126.
17. Trescot A, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11:S133-53.
18. Nestler EJ. Molecular neurobiology of addiction. Am J Addict. 2001;10:201-17.
19. Roset P, Farre M, de la Torre R, et al. Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend. 2001;64:285-98.
20. Kathiramalainathan K, Kaplan HL, Romach MK, et al. Inhibition of cytochrome P450 2D6 modifies codeine abuse liability. J Clin Psychopharmacol. 2000;20:435-44.
21. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001;2:119-28 [Erratum, Nat Rev Neurosci 2001;2:215].
22. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58-63.
23. Christie MJ. Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol. 2008;154:384-96.
24. Sarnyai Z, Shaham Y, Heinrichs SC. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev. 2001;53:209-43.
25. Lim G, Wang S, Zeng Q, et al. Spinal glucocorticoid receptors contribute to the development of morphine tolerance in rats. Anesthesiology. 2005;102:832-7.
26. O'Brien C. Chapter 23. Drug addiction and drug abuse (Chapter). In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s the pharmacological basis of therapeutics, 11e: http://www.accessmedicine.com/content.aspx?aID=941547. Accessed 30 Sep 2010.
27. Knaggs RD, Crighton IM, Cobby TF, et al. The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesth Analg. 2004;99:108-12.
28. Traub SJ, Hoffman RS, Nelson LS. Body packing. The internal concealment of illicit drugs. N Engl J Med. 2003;349:2519.
29. Doyon S. Chapter 167. Opioids. In: Tintinalli JE, Kelen GD, Stapczynski JS, Ma OJ, Cline DM, editors. Tintinalli’s emergency medicine: a comprehensive study guide, 6e: http://www.access-medicine.com.medlib.med.miami.edu:2048/content.aspx?aID=602227. Accessed 30 Sep 2010.
30. Sporer K, Dorn EA. Case series. Heroin-related noncardiogenic pulmonary. Chest. 2001;120:1628-32.
31. Cygan J, Trunsk M, Corbridge T. Inhaled heroin-induced status asthmaticus: five cases and a review of the literature. Chest. 2000;117:272-5.
32. Nafziger AN, Bertino Jr JS. Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain. 2009;25(1):73-9.
33. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008;83(1):66-76.
34. Amitai Y, Silver B, Leikin JG, et al. Detection of tablets in the gastrointestinal tract by ultrasound. Am J Emerg Med. 1992;10:18.
35. Florez MV, Evans JM, Daly TR. The radiodensity of medications seen on x-ray films. Mayo Clin Proc. 1998;73:516.
36. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy. 2003;23:802.
37. Altmann D, Eggmann U, Ammann PW. Drug induced QT prolongation. Klin Wochenschr. 2008; 120(5-6): 128-35.
38. Gupta A, Lawrence AT, Krishnan K, et al. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J. 2007;153(6):891-9.
39. Letsas KP, Efremidis M, Kounas SP, et al. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol. 2009;98(4):208-12.
40. Kies SJ, Pabelick CM, Hurley HA, et al. Anesthesia for patients with congenital long QT syndrome. Anesthesiology. 2005;102(1):204-10.
41. Charbit B, Alvarez JC, Dasque E, et al. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology. 2008;109(2):206-12.
42. Yildirim H, Adanir T, Atay A, et al. The effects of sevoflurane, isoflurane and desflurane on QT interval of the ECG. Eur J Anaesthesiol. 2004;21(7):566-70.
43. Nakao S. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients. Anesth Analg. 2010;110(3):775-9.
44. Stork CM, Redd JT, Fine K, Hoffman RS. Propoxyphene-induced wide QRS complex dysrhythmia responsive to sodium bicarbonate. A case report. J Toxicol Clin Toxicol. 1995;33:179.
45. Saybolta M, Altera S, Santosb F, et al. Naloxone in cardiac arrest with suspected opioid overdoses. Resuscitation. 2010;81:42-6.
46. Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226-38.
47. Mokhlesi B, Leiken J, Murray P, et al. Adult toxicology in critical care: part II: specific poisonings. Chest. 2003;123:897-922.
48. Schneir AB, Vadeboncoeur TF, Offerman SR, et al. Massive OxyContin ingestion refractory to naloxone therapy. Ann Emerg Med. 2002;40(4):425-8.
49. Larpin R, Vincent A, Perret C. Hospital morbidity and mortality of acute opiate intoxication. Presse Med. 1990;19(30):1403-6.
50. Grigorakos L, Sakagianni K, Tsigou E, et al. Outcome of acute heroin overdose requiring intensive care unit admission. J Opioid Manag. 2010;6(3):227-31.
51. Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness: controversies in the use of a ‘coma cocktail’. JAMA. 1995;274:562.
52. Hamad A, Al-Ghadban A, Carvounis C, et al. Predicting the need for medical intensive care. J Intensive Care Med. 2000;15(6):321-8.
53. Shapiro R. Liability issues in the management of pain. J Pain Symptom Manage. 1994;9(3): 146-52.
54. Lawrence L. Legal issues in pain management: striking the balance. Emerg Med Clin North Am. 2005;23(2):573-84.
55. Fitzgibbon D, Rathmell J, Michna E, et al. Malpractice claims associated with medication management for chronic pain. Anesthesiology. 2010;112:948-56.
56. Sullivan M, Edlund M, Zhang L, et al. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166:2087-93.
57. May JA, White HC, Leonard-White A, et al. The patient recovering from alcohol or drug addiction: special issues for the anesthesiologist. Anesth Analg. 2001;92:160-1.
58. Jage J, Bey T. Postoperative analgesia in patients with substance use disorders. Acute Pain. 2000;3:140-55.
59. Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal [see comment]. N Engl J Med. 2003;348(18):1786-95.
60. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology. 2004;101:212-27.
61. Mehta V, Langford RM. Pain management for opioid dependent patients. Anaesthesia. 2006;61:269-76.
62. Tetrault JM, O'Connor PJ. Substance abuse and withdrawal in the critical care setting. Crit Care Clin. 2008;24:767-88.
63. Rapp SE, Ready LB, Nessly ML. Acute pain management in patients with prior opioid consumption: a case controlled retrospective review. Pain. 1995;61:195-201.
64. Chrysostomou C, Schmitt CG. Dexmedetomidine: sedation, analgesia and beyond. Expert Opin Drug Metab Toxicol. 2008;4(5):619-27.
65. Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol. 2009;22(5):588-93.
66. Katz WA. Cyclooxygenase-2-selective inhibitors in the management of acute and perioperative pain. Cleve Clin J Med. 2002;69 Suppl 1:S165-75.
67. Chen JY, Ko TL, Wen YR, et al. Opioid-sparing effects of ketorolac and its correlation with the recovery of postoperative bowel function in colorectal surgery patients: a prospective randomized double-blinded study. Clin J Pain. 2009;25(6):485-9.
68. Bell RF, Dahl JB, Moore RA, Kalso E. Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol Scand. 2005;49(10): 1405-28.
69. Haller G, Waeber JL, Infante NK, Clergue F. Ketamine combined with morphine for the management of pain in an opioid addict. Anesthesiology. 2002;96:1265-6.
70. Nicholls L, Bragaw L, Ruetsch C. Opioid dependence treatment and guidelines. J Manag Care Pharm. 2010;16(1 Suppl B):S14-21.
71. Kleber HS. Opioids: detoxification. In: GalanterM, KleberHD, editors. Textbookof substance abuse treatment. 2nd ed. Washington, DC: The American Psychiatric Press; 1999. p. 251-69.
72. O'Connor PG, Samet JH, Stein MD. Management of hospitalized intravenous drug users: role of the internist. Am J Med. 1994;96:551-8.
73. Mackenzie JW. Acute pain management for opioid dependent patients. Anaesthesia. 2006;61:907-8.
74. Honey BL, Benefield RJ, Miller JL, Johnson PN. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009;43(9): 1506-11.
75. Tobias JD. Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. J Opioid Manag. 2006;2:201-5.
76. Baddigam K, Russo P, Russo J, Tobias JD. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med. 2005;20:118-23.
77. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage. 2000;20:237-45.
78. Laulin JP, Celerier E, Larcher A, et al. Opiate tolerance to daily heroin administration. An apparent phenomenon associated with enhanced pain sensitivity. Neuroscience. 1999;89:631-6.
79. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain. 2002;18(Suppl):S3-13.
80. Coursin DB, Coursin DB, Maccioli GA. Dexmedetomidine. Curr Opin Crit Care. 2001;7: 221-6.
81. Weinbroum AA, Gorodetzky A, Nirkin A, et al. Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study. Cancer. 2002;95:1164-70.
82. Weinbroum AA. Dextromethorphan reduces immediate and late postoperative analgesic requirements and improves patients’ subjective scorings after epidural lidocaine and general anesthesia. Anesth Analg. 2002;94:1547-52.
83. Helmy SA, Bali A. The effect of the preemptive use of the NMDA receptor antagonist dextromethorphan on postoperative analgesic requirements. Anesth Analg. 2001;92:739-44.
84. Dirks J, Fredensborg BB, Christensen D, et al. A randomized study of the effects of singledose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. Anesthesiology. 2002;97:560-4.
85. Barton SF, Langeland FF, Snabes MC, et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology. 2002;97:306-14.
86. Angst MS, Clark JD. Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain: a unique indication? Anesthesiology. 2010;113(3):514-5.
87. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;(3):CD002025.
88. Gowing L, Ali R, White JM. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database Syst Rev. 2010;(1):CD002022.